STANDARD BIOTOOLS INC. reported the quarter ended March 31, 2026 results: revenue $21.1 million, net income $14.6 million. Guidance reaffirmed.
“(NASDAQ: LAB) (the “Company” or “Standard BioTools”) today announced financial results for the quarter ended March 31, 2026. Recent Highlights: • First quarter 2026 revenue of $21.1 million • 54% reduction in operating loss and 78% improvement in adjusted EBITDA year-over-year supporting path to positive adjusted EBITDA exiting 2026 • $524 million in cash &”
NPOEnpro Inc.
Enpro Inc. reported quarter ended March 31, 2026 results: revenue $303.0 million, net income $27.4 million, EPS $1.29. Guidance raised.
“Enpro Reports First Quarter 2026 Results; Raises Full-Year Guidance First Quarter 2026 Highlights (All results reflect comparisons to prior-year period, unless otherwise noted) • Sales of $303.0 million up 10.9% • AST sales up 11.1%; Sealing Technologies sales up 10.8% • Net income of $27.4 million versus $24.5 million • Adjusted EBITDA* of $76.4 million versus $67.8 million • GAAP diluted earnings per share of $1.29 versus $1.15 • Adjusted diluted earnings per share* of $2.14 versus $1.90 • Raising full-year 2026 guidance: Revenue growth in the range of 10% to 14%, adjusted EBITDA* in the range of $315 million to $330 million and adjusted diluted earnings per share* in the range of $8.85 to $9.50”
HYHYSTER-YALE, INC.
HYSTER-YALE, INC. reported three months ended March 31, 2026 results: revenue $795.2 million, net income $(30.5) million, EPS $(1.71) per diluted share.
“Consolidated Highlights: • Q1 bookings continued to strengthen, up 7% sequentially, signaling early stabilization following the Q3 2025 cyclical low • Consolidated revenues of $795 million declined 13% year-over-year and 14% sequentially, primarily driven by a shift toward lighter‐duty, lower‐priced trucks and depletion of excess backlog • Operating loss of $28”
HYHYSTER-YALE, INC.
HYSTER-YALE, INC. reported first quarter 2026 results: revenue $795.2 million, net income ($30.5 million).
Neuronetics, Inc. reported three months ended March 31, 2026 results: revenue $34.5 million, net income $(10.8) million, EPS $(0.16) per share. Guidance reaffirmed.
“Total revenue for the three months ended March 31, 2026 was $34.5 million, an increase of $2.5 million, or 8%, compared to the three months ended March 31, 2025 revenue of $32.0 million.”
JAZZJazz Pharmaceuticals plc
Jazz Pharmaceuticals plc reported first quarter of 2026 (1Q26) results: revenue $1.1 billion, EPS $4.43 / $6.34. Guidance reaffirmed.
“filing. --- EX-99.1 (EX-99.1) --- Jazz Pharmaceuticals Announces First Quarter 2026 Financial Results – Strong commercial execution across franchises with total revenues of $1.1 billion (+19% YoY) – – Zanidatamab HER2+ 1L GEA sBLA granted Priority Review; PDUFA date of August 25, 2026 – – Xywav ® revenues grew 18% YoY with 425 net patient adds – – Epidiolex ®”
GOODGLADSTONE COMMERCIAL CORP
GLADSTONE COMMERCIAL CORP reported first quarter ended March 31, 2026 results: net income $3.8 million, EPS $0.08 per share.
“Net income available to common stockholders and Non-controlling OP Unitholders for the three months ended March 31, 2026 was $3.8 million, or $0.08 per share”
TDGTransDigm Group INC
TransDigm Group INC reported second quarter ended March 28, 2026 results: revenue $2,544 million, net income $536 million, EPS $9.20. Guidance raised.
“and supplier of highly engineered aircraft components, today reported results for the second quarter ended March 28, 2026. Second quarter highlights include: • Net sales of $2,544 million, up 18% from $2,150 million in the prior year's quarter; • Net income of $536 million, up 12% from the prior year's quarter; • Earnings per share of $9.20, up 12% from the prior”
WLKWESTLAKE CORP
WESTLAKE CORP reported first quarter 2026 results: revenue $2,652, net income Net loss attributable to Westlake Corporation $ (169), EPS Diluted loss per common share $ (1.31).
“except per share data and percentages) Three Months Ended March 31, 2026 Three Months Ended December 31, 2025 Three Months Ended March 31, 2025 Westlake Corporation Net sales $ 2,652 $ 2,533 $ 2,846 Loss from operations $ (172) $ (671) $ (32) Net loss attributable to Westlake Corporation $ (169) $ (544) $ (40) Diluted loss per common share $ (1.31) $ (4.22) $”
AIZASSURANT, INC.
ASSURANT, INC. reported Q1 2026 results: net income 274.1, EPS 5.41. Guidance raised.
“Assurant Increases Full Year Outlook on Record First Quarter Results Strong Start to 2026 Led by Record Earnings in Global Lifestyle 2026 to Deliver Strong Underlying Growth Driven by Global Lifestyle Adjusted EBITDA Growth of Approximately 10% (Unaudited) Q1'26 Q1'25 Change $ in millions, except per share data GAAP net income 274.1 146.6 87% Adjusted EBITDA 1 441.5 282.2 56% Adjusted EBITDA, ex. reportable catastrophes 2 465.9 439.2 6% GAAP net income per diluted share 5.41 2.83 91% Adjusted earnings per diluted share 3 5.95 3.39 76% Adjusted earnings, ex. reportable catastrophes, per diluted share 4 6.33 5.79 9% Note: The metrics included within the company’s outlook and certain other metrics are”
AIZASSURANT, INC.
ASSURANT, INC. reported financial results for quarter ended March 31, 2026.
“On May 5, 2026 , Assurant, Inc. (the “Company”) issued a news release announcing its financial results for the quarter ended March 31, 2026. The text of the news release, attached hereto as Exhibit 99.1, is incorporated by reference into this Item 2.02.”
ETEnergy Transfer LP
Energy Transfer LP reported the quarter ended March 31, 2026 results: net income $1.25 billion, EPS $0.35. Guidance raised.
“Energy Transfer reported net income attributable to partners for the three months ended March 31, 2026 of $1.25 billion”
HTGCHercules Capital, Inc.
Hercules Capital, Inc. reported first quarter ended March 31, 2026 results: revenue $141.5 million, net income $88.1 million, EPS $0.48 per share.
“Record Q1 2026 Total Investment Income of $141.5 Million, and Increase of 18.4% Year-over-Year Q1 2026 Net Investment Income "NII" of $88.1 Million, an Increase of 13.8% Year-over-Year Q1 2026 NII of $0.48 per Share provides 120% Coverage of the Base Cash Distribution”
HURNHuron Consulting Group Inc.
Huron Consulting Group Inc. reported the quarter ended March 31, 2026 results: revenue $443.7 million, net income $23.2 million, EPS $1.34 per diluted share. Guidance reaffirmed.
“Results and Affirms Full Year 2026 Guidance FIRST QUARTER 2026 FINANCIAL HIGHLIGHTS • Revenues before reimbursable expenses (RBR) increased $48.0 million, or 12.1%, to a record $443.7 million in Q1 2026 from $395.7 million in Q1 2025. • Net income was $23.2 million in Q1 2026, compared to $24.5 million in Q1 2025. • Adjusted EBITDA (9) , a non-GAAP financial measure,”
CVGICommercial Vehicle Group, Inc.
Commercial Vehicle Group, Inc. reported first quarter ended March 31, 2026 results: revenue $171.5 million, net income $0.9 million, EPS $0.03 per diluted share. Guidance reaffirmed.
“• Revenues of $171.5 million, up 1.0%, primarily driven by 14% growth in our Global Electrical Systems segment. • Operating income of $14.7 million, which included $14.0 million gain on sale of assets, was up $13.3 million, compared to $1.4 million. Adjusted operating income of $2.0 million, relatively flat compared to $2.1 million. • Net income from continuing operations of $0.9 million, or $0.03 per diluted share and adjusted net loss of $3.4 million, or $(0.10) per diluted share, compared to net loss from continuing operations of $3.1 million, or $(0.09) per diluted share and adjusted net loss of $2.6 million, or $(0.08) per diluted share.”
SHOSunstone Hotel Investors, Inc.
Sunstone Hotel Investors, Inc. reported first quarter ended March 31, 2026 results: net income $16.0 million, EPS $0.08 per diluted share.
“quarter ended March 31, 2026. First Quarter 2026 Operational Results (as compared to First Quarter 2025): ● Net Income: Net income attributable to common stockholders was $16.0 million, or $0.08 per diluted share, as compared to $1.3 million, or $0.01 per diluted share. ● RevPAR : RevPAR for all hotels in the portfolio increased 14.6% to $255.04. The average”
BXCBlueLinx Holdings Inc.
BlueLinx Holdings Inc. reported fiscal first quarter ended April 4, 2026 results: revenue $731 million, net income Net loss of $1.5 million, EPS $0.18 loss per share. Guidance initiated.
“Net sales of $731 million • Gross profit of $116 million, or 15.9% of net sales • Net loss of $1.5 million, or $0.18 loss per share • Adjusted net income of $1.7 million, or $0.21 adjusted diluted earnings per share”
CECelanese Corp
Celanese Corp updated its first quarter 2026 guidance (raised).
“Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today reported first quarter 2026 U.S. GAAP diluted earnings per share of $0.41 and adjusted earnings per share of $0.85. Net sales of $2.3 billion increased 6 percent sequentially, reflecting a 5 percent increase in volume, a small currency benefit and stable pricing.”
ATRCAtriCure, Inc.
AtriCure, Inc. reported first quarter ended March 31, 2026 results: revenue $141.2 million, net income $0.1 million, EPS breakeven at $0.00.
“or document. --- EX-99.1 (EX-99.1) --- For immediate release May 5, 2026 AtriCure Reports First Quarter 2026 Financial Results • First Quarter 2026 worldwide revenue of $141.2 million, an increase of 14.3% year over year • First Quarter 2026 profitability improved, with net income of $0.1 million and adjusted EBITDA of $17.1 million • U.S. revenue growth”
DUKDuke Energy CORP
Duke Energy CORP reported first quarter ended March 31, 2026 results: EPS $1.97. Guidance reaffirmed.
“Duke Energy (NYSE: DUK) today announced first-quarter 2026 reported EPS of $1.97, prepared in accordance with Generally Accepted Accounting Principles (GAAP), and adjusted EPS of $1.93.”
LYVLive Nation Entertainment, Inc.
Live Nation Entertainment, Inc. reported quarter ended March 31, 2026 results: revenue $3.8 billion. Guidance reaffirmed.
“LIVE NATION ENTERTAINMENT REPORTS FIRST QUARTER 2026 RESULTS “2026 is off to a powerful start, with first quarter revenue climbing 12% to $3.8 billion.”
LDOSLeidos Holdings, Inc.
Leidos Holdings, Inc. reported first fiscal quarter ended April 3, 2026 results: revenue $4.4 billion, net income $335 million, EPS $2.56 per diluted share. Guidance raised.
“be expressly set forth by specific reference in such filing. --- EX-99.1 (EX-99.1) --- Leidos Posts Strong First Quarter Results and Raises Full-Year Guidance u Revenues of $4.4 billion, up 4% year-over-year u Net income of $335 million or $2.56 per diluted share u Adjusted EBITDA (non-GAAP) of $614 million and Adjusted EBITDA margin (non-GAAP) of 14.0% u”
MWAMueller Water Products, Inc.
Mueller Water Products, Inc. reported fiscal 2026 second quarter ended March 31, 2026 results: revenue $384.4 million, net income $59.1 million, EPS $0.38 per diluted share. Guidance raised.
“MUELLER WATER PRODUCTS REPORTS 2026 SECOND QUARTER RESULTS Increased Net Sales 5.5% to $384.4 Million Reported Net Income per Diluted Share of $0.38 Achieved Adjusted Net Income per Diluted Share of $0.40 Raises Annual Guidance for Fiscal 2026 Adjusted EBITDA ATLANTA, May 5, 2026 - Mueller Water Products, Inc. (NYSE: MWA), a leading manufacturer and marketer of products and solutions used in the transmission, distribution and measurement of water in North America, announced financial results for its fiscal 2026 second quarter ended March 31, 2026. In the second quarter of 2026, the Company: • Increased net sales 5.5% to $384.4 million as compared with $364.3 million in the prior year quarter • Reported operating income of $80.4 million as compared with $69.9 million in the prior year quarter, and increased adjusted operating income 16.0% to $84.8 million as compared with $73.1 million in the prior year quarter • Reported operating margin of 20.9% as compared with 19.2% in the prior yea”
ATECAlphatec Holdings, Inc.
Alphatec Holdings, Inc. reported the quarter ended March 31, 2026 results: revenue $192 million, net income ($34) million. Guidance reaffirmed.
“today announced financial results for the quarter ended March 31, 2026, and business highlights. First Quarter 2026 Financial Results Quarter Ended March 31, 2026 Total revenue $192 million GAAP gross margin 71% Non-GAAP gross margin 72% GAAP operating expenses $159 million Non-GAAP operating expenses $132 million GAAP net income / (loss) ($34) million Non-GAAP net”
SUPNSUPERNUS PHARMACEUTICALS, INC.
SUPERNUS PHARMACEUTICALS, INC. reported the first quarter ended March 31, 2026 results: revenue $207.7 million. Guidance reaffirmed.
“Supernus Announces First Quarter 2026 Financial Results • Total revenues were $207.7 million in the first quarter 2026”
KBRKBR, INC.
KBR, INC. reported first quarter fiscal 2026 results: revenue $1.9 billion, net income $102 million, EPS $0.80.
“KBR Reports First Quarter Fiscal 2026 Results First Quarter Fiscal 2026 Results (All comparisons against the first quarter fiscal 2025 unless noted.) • Revenues of $1.9 billion, down 5% due to expected EUCOM contingency runoff • Net income attributable to KBR of $102 million, down 12%; Operating income of $180 million, down 11% with an Operating income margin of 9.4% • Adjusted EBITDA 2 of $251 million, up 1% with an Adjusted EBITDA 2 margin of 13.1% • Diluted EPS attributable to KBR of $0.80, down 9%”
DTILPRECISION BIOSCIENCES INC
PRECISION BIOSCIENCES INC reported financial results for first quarter ended March 31, 2026.
“Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today reported financial results for the first quarter ended March 31, 2026, and provided a business update.”
PRIMPrimoris Services Corp
Primoris Services Corp reported first quarter ended March 31, 2026 results: revenue $1.6 billion, net income $17.4 million, or $0.32 per diluted share, EPS $0.32 per diluted share.
“For the first quarter of 2026, Primoris reported the following highlights (1) : ● Revenue of $1.6 billion, down $0.1 billion, or 5.4%, compared to the first quarter of 2025 primarily driven by lower revenue in the Energy segment, partially offset by growth in the Utilities segment; ● Net income of $17.4 million, or $0.32 per diluted share, down $26.8 million, or $0.49 per diluted share, from the first quarter of 2025;”
DEIDouglas Emmett Inc
Douglas Emmett Inc reported the quarter ended March 31, 2026 results: revenue $251, net income $(2), EPS $0.37. Guidance reaffirmed.
“in our current portfolio can now accommodate 8,000 - 10,000 new units. Comparative Financial Results Quarterly (In millions, except per share data) Q1 2026 Q1 2025 Revenues $251 $252 Net (loss) income attributable to common stockholders $(2) $40 FFO per fully diluted share $0.37 $0.40 AFFO $49 $62 Same Property Cash NOI $152 $155 Leasing: We recorded”
OCGNOcugen, Inc.
Ocugen, Inc. reported financial results for quarter ended March 31, 2026.
“On May 5, 2026, Ocugen, Inc (the “Company”) issued a press release announcing certain financial results for the quarter ended March 31, 2026.”
SMCISuper Micro Computer, Inc.
Super Micro Computer, Inc. reported third quarter of fiscal year 2026 ended March 31, 2026 results: revenue $10.2 billion, net income $483 million, EPS $0.72. Guidance reaffirmed.
“and 5G/Edge, today announced unaudited financial results for its third quarter of fiscal year 2026 ended March 31, 2026. Third Quarter Fiscal Year 2026 Highlights • Net sales of $10.2 billion versus $12.7 billion in Q2'26 and $4.6 billion in Q3'25. • Gross margin of 9.9% versus 6.3% in Q2'26 and 9.6% in Q3'25. • Net income of $483 million versus $401 million in Q2'26”
PTGXProtagonist Therapeutics, Inc
Protagonist Therapeutics, Inc reported first quarter ended March 31, 2026 results: revenue License and collaboration revenue $ 56,368, net income Net income (loss) $ 3,783, EPS Diluted earnings (loss) per share $ 0.05.
“to $646.0 million as of December 31, 2025. Three Months Ended March 31, 2026 2025 (in thousands, except per share amounts) (Unaudited) License and collaboration revenue $ 56,368 $ 28,321 Research and development expense $ 46,739 $ 35,893 General and administrative expense $ 13,277 $ 11,738 Income tax benefit $ 1,502 $ - Net income (loss) $ 3,783 $ (11,655”
SARSARATOGA INVESTMENT CORP.
SARATOGA INVESTMENT CORP. reported financial results for the quarter and full year ended February 28, 2026.
“On May 5, 2026, Saratoga Investment Corp. issued a press release announcing its financial results for the quarter and full year ended February 28, 2026.”
VCYTVERACYTE, INC.
VERACYTE, INC. reported first quarter ended March 31, 2026 results: revenue $139.1 million, net income $28.7 million.
“Key Financial Highlights For the three-month period ended March 31, 2026, as compared to the same period in 2025: • Increased total revenue by 21% to $139.1 million and testing revenue by 26% to $135.1 million, driven by Decipher growth of 30% to $86.5 million and Afirma growth of 21% to $46.4 million. • Increased total volume by 17% to 47,615 tests and testing volume by 19% to 45,248 tests, driven by Decipher growth of 24% to approximately 28,000 tests and Afirma growth of 12% to approximately 17,200 tests. • Recorded GAAP net income of $28.7 million, or 20.6% of revenue, and delivered adjusted EBITDA of $42.8 million, or 30.8% of revenue.”
GLREGREENLIGHT CAPITAL RE, LTD.
GREENLIGHT CAPITAL RE, LTD. reported first quarter March 31, 2026 results: revenue $154.1 million, net income $35.8 million, EPS $1.05.
“Gross premiums written decreased 8% to $227.9 million; • Net premiums earned decreased 8% to $154.1 million; • Net underwriting income of $6.2 million, compared to an underwriting loss of $7.8 million; • Combined ratio of 96.0%, compared to 104.6%; • Total investment income of $40.4 million, compared to $40.5 million; • Net income of $35.8 million, or $1.05 per diluted ordinary share, compared to net income of $29.6 million, or $0.86 per diluted ordinary share; • Repurchased $5 million of ordinary shares at an average cost of $16.70 per share; and • Fully diluted book value per share increased 4.7% to $21.40, from $20.43 at December 31, 2025.”
OCULOCULAR THERAPEUTIX, INC
OCULAR THERAPEUTIX, INC reported financial results for first quarter ended March 31, 2026.
“On May 5, 2026, Ocular Therapeutix, Inc. announced its financial results for the quarter ended March 31, 2026.”
AMWLAmerican Well Corp
American Well Corp reported Q2 2026 results: revenue $48- $52 million. Guidance initiated.
“The company also provided financial guidance for Q2 2026 Revenue and adjusted EBITDA: • Q2 revenue in the range of $48- $52 million • Q2 adjusted EBITDA in the range of ($4) – ($2) million.”
AMWLAmerican Well Corp
American Well Corp reported 2026 full year results: revenue $195 to $205 million. Guidance reaffirmed.
“The company reaffirmed its 2026 revenue and AMG visits guidance and updated its Adjusted EBITDA outlook: • Revenue in the range of $195 to $205 million • AMG visits between 1.32 and 1.37 million • Adjusted EBITDA in the range of between ($16) million to ($12) million.”
AMWLAmerican Well Corp
American Well Corp reported Q1 2026 results: revenue Recorded Total Revenue of $54.9 million, net income Net loss was ($10.3) million.
“Recorded Total Revenue of $54.9 million exceeding the previously provided financial guidance for Q1 o Achieved subscription revenue of $24.9 million o Recorded Amwell Medical Group (“AMG”) visit revenue of $28.9 million • Reported gross margin of 51% • Net loss was ($10.3) million, compared to ($25.2) million in fourth quarter of 2025, continuously moving from quarter to quarter in a favorable trajectory”
DHXDHI GROUP, INC.
DHI GROUP, INC. reported financial results for the first quarter ended March 31, 2026.
“On May 5, 2026, DHI Group, Inc. (the “Company”) reported its results of operations for the fiscal quarter ended March 31, 2026. A copy of the press release issued by the Company concerning the foregoing is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.”
OPLNOPENLANE, Inc.
OPENLANE, Inc. reported three months ended March 31, 2026 results: revenue $528 million, net income $49 million. Guidance raised.
“• Revenue of $528 million, representing 15% YoY growth, driven by 22% growth in auction and related fees • Net income of $49 million, representing 33% YoY growth • Adjusted EBITDA of $97 million, representing 17% YoY growth”
ACICAMERICAN COASTAL INSURANCE Corp
AMERICAN COASTAL INSURANCE Corp reported financial results for first quarter ended March 31, 2026.
“American Coastal Insurance Corporation (Nasdaq: ACIC) ("ACIC" or the "Company"), a property and casualty insurance holding company, today reported its financial results for the first quarter ended March 31, 2026.”
KKRKKR & Co. Inc.
KKR & Co. Inc. reported financial results for the quarter ended March 31, 2026.
“On May 5, 2026, KKR & Co. Inc. issued an earnings release announcing its financial results for the quarter ended March 31, 2026.”
GPKGRAPHIC PACKAGING HOLDING CO
GRAPHIC PACKAGING HOLDING CO reported first quarter 2026 results: revenue $2,156 million, net income ($43) million, EPS $(0.14) per diluted share. Guidance reaffirmed.
“GPK) ("Graphic Packaging" or the "Company"), a global leader in sustainable consumer packaging, today reported first quarter 2026 results. Net Sales in first quarter 2026 were $2,156 million, versus $2,120 million in first quarter 2025. Net Loss in first quarter 2026 was ($43) million, or $(0.14) per diluted share, versus Net Income of $127 million, or $0.42 per”
EFCEllington Financial Inc.
Ellington Financial Inc. reported the quarter ended March 31, 2026 results: net income Net income attributable to common stockholders of $95.5 million, or $0.78 per common share., EPS $0.78 per common share.
“Ellington Financial Inc. Reports First Quarter 2026 Results OLD GREENWICH, Connecticut—May 5, 2026 Ellington Financial Inc. (NYSE: EFC) ("we") today reported financial results for the quarter ended March 31, 2026. Highlights • Net income attributable to common stockholders of $95.5 million, or $0.78 per common share.”
AMCAMC ENTERTAINMENT HOLDINGS, INC.
AMC ENTERTAINMENT HOLDINGS, INC. reported first quarter ended March 31, 2026 results: revenue $1,045.4 million, net income $(117.1) million, EPS $(0.22).
“● Total revenues were $1,045.4 million compared to $862.5 million. ● Net loss was $(117.1) million compared to $(202.1) million.”
OCSLOaktree Specialty Lending Corp
Oaktree Specialty Lending Corp reported second fiscal quarter ended March 31, 2026 results: revenue $70.4 million, net income $34.4 million, EPS $0.39 per share.
“today announced its financial results for the second fiscal quarter ended March 31, 2026. Financial Highlights for the Quarter Ended March 31, 2026 • Total investment income was $70.4 million ($0.80 per share) for the second fiscal quarter of 2026 as compared to $75.1 million ($0.85 per share) for the first fiscal quarter of 2026. Adjusted total investment income was”
SLRCSLR Investment Corp.
SLR Investment Corp. reported for the quarter ended March 31, 2026 results: net income $17.9 million or $0.33 per share, EPS $0.33 per share.
“NEW YORK, May 05, 2026 (GLOBE NEWSWIRE) -- SLR Investment Corp. (NASDAQ: SLRC) (the “Company”, “SLRC”, “we”, “us”, or “our”) today reported net investment income (“NII”) of $17.9 million, or $0.33 per share, for the first quarter of 2026. On May 5, 2026, the Board declared a quarterly distribution of $0.31 per share payable on June 26, 2026, to holders of record”
ATOMAtomera Inc
Atomera Inc reported the first quarter ended March 31, 2026 results: net income ($6.1) million, or ($0.17) per basic and diluted share, EPS ($0.17) per basic and diluted share.
“With this additional capital we are in a strong position to enable our customers to bring MST-enabled products to market.” Financial Results The Company incurred a net loss of ($6.1) million, or ($0.17) per basic and diluted share in the first quarter of 2026, compared to a net loss of ($5.2) million, or ($0.14) per basic and diluted share, for the first”
MGMistras Group, Inc.
Mistras Group, Inc. reported first quarter ended March 31, 2026 results: revenue $169.0 million, net income $2.4 million, EPS $0.07.
“• Revenue of $169.0 million , an increase of 4.6%, driven by strong growth of 35.5% in Aerospace & Defense • Gross profit of $ 44.7 million , reflecting a gross profit margin of 26.5%, an increase of 120 basis points • Income from Operations of $4.7 million, an increase of $5.7 million, or 562.6% • GAAP net income of $2.4 million, with earnings per diluted share of $0.07 • Adjusted EBITDA of $14.3 million”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.